Back to search
Gallbladder Neoplasm Malignant Primary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Gallbladder Neoplasm Malignant Primary trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Gallbladder Neoplasm Malignant Primary trials you may qualify forThe iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimens…
The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
This is a research study of an experimental drug called ACC-1898. ACC-1898 is an oral tyrosine kinase inhibitor (TKI) that blocks several proteins kinases which…
The goal of this clinical randomized controlled trial is to perform primary percutaneous stenting (PPS) in patients with malignant hilar biliary obstruction (MH…